Cited 0 times in
Cited 0 times in
Aggressive serous ovarian cancer subtype defined by high centrality lncRNA profiles and master transcription factors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박선미 | - |
dc.contributor.author | 이잔디 | - |
dc.contributor.author | 조영석 | - |
dc.date.accessioned | 2025-08-18T05:19:13Z | - |
dc.date.available | 2025-08-18T05:19:13Z | - |
dc.date.issued | 2025-07 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/207032 | - |
dc.description.abstract | Long non-coding RNAs (lncRNAs) regulate the progression and metastasis of high-grade serous carcinoma ovarian cancer (HGSC). However, HGSC is yet to be classified based on these transcripts. In addition, the crosstalk between master transcriptional factors (MTFs) and lncRNAs remains unclear. Therefore, we aimed to classify HGSC based on lncRNA expression and identify the integrated MTFs for highly correlated mRNAs and lncRNAs. Unsupervised clustering was conducted using highly expressed lncRNAs derived from 367 HGSC samples obtained from The Cancer Genome Atlas. DNA mutations, somatic copy number alterations, microRNA expression, and DNA methylome were analyzed to identify the genetic and epigenetic factors affecting unsupervised clustering. Multiple Sample Virtual Inference of Protein-activity by Enriched Regulon analysis (msViper) was conducted to identify transcription factors simultaneously exhibiting positive correlation with lncRNAs and mRNAs in each cluster. In vitro analyses were performed to determine if these lncRNAs regulate both the MTFs and target genes. Functional analysis enabled the lncRNA-based classification of HGSC into five groups: "Immune," "EMT," "Estrogen response," "EMT-Androgen response," and "Differentiation" groups. The EMT-Androgen response group showed poor prognosis in the oncologic outcome. Of the transcription factors selected in this group, three MTFs with the highest eigenvector centrality scores were identified (MSC, AEBP1, CREB3L1). However, seven lncRNAs exerted a higher centrality than the selected MTFs. Our results suggest that HGSC can be classified based on lncRNA expression and characterized using molecular features. Therefore, lncRNAs and MTFs may synergistically contribute to molecular features of HGSC that could be indicators for personalized medicine. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Nature Publishing Group | - |
dc.relation.isPartOf | SCIENTIFIC REPORTS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Cystadenocarcinoma, Serous* / genetics | - |
dc.subject.MESH | Cystadenocarcinoma, Serous* / pathology | - |
dc.subject.MESH | DNA Methylation | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Gene Expression Profiling | - |
dc.subject.MESH | Gene Expression Regulation, Neoplastic | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Ovarian Neoplasms* / classification | - |
dc.subject.MESH | Ovarian Neoplasms* / genetics | - |
dc.subject.MESH | Ovarian Neoplasms* / pathology | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | RNA, Long Noncoding* / genetics | - |
dc.subject.MESH | RNA, Long Noncoding* / metabolism | - |
dc.subject.MESH | RNA, Messenger / genetics | - |
dc.subject.MESH | Transcription Factors* / genetics | - |
dc.subject.MESH | Transcription Factors* / metabolism | - |
dc.title | Aggressive serous ovarian cancer subtype defined by high centrality lncRNA profiles and master transcription factors | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Seonhyang Jeong | - |
dc.contributor.googleauthor | Young Suk Jo | - |
dc.contributor.googleauthor | Sunmi Park | - |
dc.contributor.googleauthor | Hwayoung Lee | - |
dc.contributor.googleauthor | Eun Gyeong Park | - |
dc.contributor.googleauthor | Sang Geun Jung | - |
dc.contributor.googleauthor | Jandee Lee | - |
dc.identifier.doi | 10.1038/s41598-025-06262-9 | - |
dc.contributor.localId | A06122 | - |
dc.contributor.localId | A03066 | - |
dc.contributor.localId | A03853 | - |
dc.relation.journalcode | J02646 | - |
dc.identifier.eissn | 2045-2322 | - |
dc.identifier.pmid | 40594853 | - |
dc.subject.keyword | Biomarker | - |
dc.subject.keyword | High-grade serous ovarian cancer | - |
dc.subject.keyword | Long Noncoding RNA | - |
dc.subject.keyword | Multi-omics data | - |
dc.subject.keyword | Ovarian cancer | - |
dc.contributor.alternativeName | Park, Sunmi | - |
dc.contributor.affiliatedAuthor | 박선미 | - |
dc.contributor.affiliatedAuthor | 이잔디 | - |
dc.contributor.affiliatedAuthor | 조영석 | - |
dc.citation.volume | 15 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 20631 | - |
dc.identifier.bibliographicCitation | SCIENTIFIC REPORTS, Vol.15(1) : 20631, 2025-07 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.